Erik Nilsson

Title: The Innovations of Erik Nilsson

Introduction

Erik Nilsson is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cardiovascular disease diagnostics. With a total of 2 patents, his work focuses on innovative methods for screening and diagnosing cardiovascular conditions.

Latest Patents

Erik's latest patents include methods and compositions for the diagnosis or prognosis of cardiovascular disease. These inventions provide methods for screening a mammalian subject to determine if the subject is at risk of developing or is suffering from cardiovascular disease. One embodiment of the method involves detecting measurable features of at least two biomarkers in an HDL subfraction or in a complex containing apoA-I or apoA-II isolated from a biological sample obtained from the subject. The biomarkers selected for this method include apoA-I, apoA-II, apoB-100, Lp(a), apoC-I, and apoC-III, along with their combinations or derivatives. By comparing the measurable features of these biomarkers from the biological sample to a reference standard, a difference can indicate the presence or risk of cardiovascular disease in the subject.

Career Highlights

Throughout his career, Erik has worked with various organizations, including Insilicos, LLC and the University of Washington. His experience in these institutions has allowed him to develop and refine his innovative approaches to cardiovascular diagnostics.

Collaborations

Erik has collaborated with notable professionals in his field, including Jay W. Heinecke and Tomas Vaisar. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Erik Nilsson's contributions to the field of cardiovascular disease diagnostics through his innovative patents highlight his role as a significant inventor. His work continues to impact the medical community and improve patient outcomes.